Condition: Acute Coronary Syndrome · Coronary Bypass Stenosis · Sponsor: University Hospital, Linkoeping
The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)
This description comes directly from the study's public registry record.
Jonas Holm, MD, PhD · +46101034498 · jonas.holm@regionostergotland.se
Sofia Sederholm Lawesson, MD, PhD · +461037472 · sofia.sederholm.lawesson@regionostergotland.se
Always discuss trial participation with your own doctor first.
| Department of Heart Disease, Haukeland University Hospital | Bergen, Norway | Enrolling By Invitation |
| St Olavs University Hospital | Trondheim, Norway | Not Yet Recruiting |
| Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine | Gothenburg, Sweden | Enrolling By Invitation |
| Dep of Vascular and Thoracic Surgery | Örebro, Sweden | Active Not Recruiting |
| Department of Cardiothoracic Surgery Karolinska University Hospital | Stockholm, Sweden | Enrolling By Invitation |
| University Hospital Linköping | Linköping, Östergötland County, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04783701